Yarrow Bioscience (YARW) Debt by Year
Yarrow Bioscience, Inc. carried $0 in long-term debt against $24.0M in cash and equivalents at the end of fiscal year 2025. The change in long-term debt from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Yarrow Bioscience, Inc. has filed alongside them.
Ticker history: VYNE became YARW (Yarrow Bioscience, Inc.) on . Earlier news and filings retain their original names and dates. View VYNE history.
Annual figures, oldest first. Point at a bar to read its period.
YARW Debt & Cash by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-Q | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $0n/m | $0n/m | $0n/m | $0n/m | $0-100.0% | $33.2M+1.4% | $32.7M | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $24.0M+20.6% | $19.9M-34.9% | $30.6M-0.9% | $30.9M-26.8% | $42.3M-26.6% | $57.6M+31.5% | $43.8M+57.0% | $27.9M+173.1% | $10.2M+153.4% | $4.0M-90.8% | $43.8M |
YARW Debt & Cash by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26Filing | Q4'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Cash & Equivalents | $22.9M+4.0% | $24.6M-12.7% | $24.0M+20.6% | $22.0M-25.5% | $28.2M+48.0% | $19.9M-34.9% | $16.3M+5.3% | $29.6M+43.5% | $19.1M-36.9% | $30.6M-0.9% | $15.4M-56.5% | $20.6M-51.8% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Yarrow Bioscience, Inc. financials
Frequently Asked Questions
Yarrow Bioscience, Inc. carried $0 in long-term debt against $24.0M in cash and equivalents at the end of fiscal year 2025.
Yarrow Bioscience, Inc. (YARW) reported $0 in long-term debt in fiscal year 2024 and $0 in long-term debt in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Yarrow Bioscience, Inc. (YARW) reported $0 in long-term debt in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Yarrow Bioscience, Inc. (YARW) reported on that line in every period on record.